Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery (Q45722014)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 June 2013

Language	Label	Description	Also known as
English	Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery	scientific article published on 19 June 2013

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery (English)

1 reference

Europe PubMed Central

15 December 2017

1 reference

based on heuristic

inferred from title

tumour xenograft

1 reference

based on heuristic

inferred from title

Vasilis Ntziachristos

6

object named as

Vasilis Ntziachristos

1 reference

Europe PubMed Central

15 December 2017

author name string

Marta Kijanka

1

1 reference

Europe PubMed Central

15 December 2017

Frank-Jan Warnders

2

1 reference

Europe PubMed Central

15 December 2017

Mohamed El Khattabi

3

1 reference

Europe PubMed Central

15 December 2017

Marjolijn Lub-de Hooge

4

1 reference

Europe PubMed Central

15 December 2017

Gooitzen M van Dam

5

1 reference

Europe PubMed Central

15 December 2017

Liesbeth de Vries

7

1 reference

Europe PubMed Central

15 December 2017

Sabrina Oliveira

8

1 reference

Europe PubMed Central

15 December 2017

Paul M P van Bergen En Henegouwen

9

1 reference

Europe PubMed Central

15 December 2017

publication date

19 June 2013

1 reference

Europe PubMed Central

15 December 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

15 December 2017

40

1 reference

Europe PubMed Central

15 December 2017

11

1 reference

Europe PubMed Central

15 December 2017

1718-1729

1 reference

Europe PubMed Central

15 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-013-2471-2

0 references

Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Current technologies for HER2 testing in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Translation of near-infrared fluorescence imaging technologies: emerging clinical applications

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Molecular imaging in living subjects: seeing fundamental biological processes in a new light

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Src family kinases and HER2 interactions in human breast cancer cell growth and survival

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

A modeling analysis of the effects of molecular size and binding affinity on tumor targeting

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Evaluation of ((4-hydroxyphenyl)ethyl)maleimide for site-specific radiobromination of anti-HER2 affibody.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Preclinical evaluation of 227Th-labeled and 177Lu-labeled trastuzumab in mice with HER-2-positive ovarian cancer xenografts.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2471-2

21 January 2018

Prognostic factors in metastatic breast cancer: successes and challenges toward individualized therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23778558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23778558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions

1 reference

https://pubmed.ncbi.nlm.nih.gov/23778558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics and pharmacodynamics of monoclonal antibodies--mechanistic modeling applied to drug development.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23778558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The HER2 testing conundrum

1 reference

https://pubmed.ncbi.nlm.nih.gov/23778558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

1 reference

https://pubmed.ncbi.nlm.nih.gov/23778558

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-013-2471-2

1 reference

Europe PubMed Central

15 December 2017

Dimensions Publication ID

0 references

release_zmqnm355s5cf3lpm2uw3gz5yqy

1 reference

https://api.fatcat.wiki/v0/release/zmqnm355s5cf3lpm2uw3gz5yqy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45722014&oldid=2077820557"